跳至主要内容
临床试验/NCT02123082
NCT02123082已完成不适用

Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes

University of California, Irvine2 个研究点 分布在 1 个国家目标入组 156 人开始时间: 2014年7月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
156
试验地点
2
主要终点
Time

研究概览

简要总结

Urolithiasis (kidney stones) is a common disease process affecting people all across the world. Usually, if the stone size is small, it is able to pass through the urinary system and exit the bladder on its own with no treatment. However, when the size of the stone is bigger, it can get trapped in the kidney or the ureter, causing significant pain for the patient and potentially obstructing urine flow. If this occurs, surgical treatment is necessary for the removal of the stone. The surgical procedure often employed involves the use of a ureteroscope, which is a device that includes a camera and channels for working instruments such as a grasper and laser fiber to be placed during a procedure. Ureteroscopes that are currently in use are flexible and have the ability to treat stones that may otherwise be inaccessible in the kidney. Most flexible ureteroscopes in clinical use currently only have one channel therefore only allowing one instrument to be used at a time. Recently, a new type of ureteroscope has been introduced in the market that offers the advantage of having two working channels where two instruments can be inserted for use during stone treating procedure. This can potentially decrease procedure time for patients affected by kidney stones.

The purpose of this research is to compare the efficacy and safety of the ureteroscopes that have only one channel for instrument insertion with the newer ureteroscope that has two channels for utilization during stone treatment.

详细描述

Study design

This study will be prospective, multi-institutional randomized controlled trial comparing single lumen and dual lumen ureteroscopes. Specifically, a new double-lumen ureteroscope will be compared in a multicenter trial with the currently existing single-lumen ureteroscopes in patients undergoing ureteroscopy for stones in the kidney and ureter.

Patient Recruitment and Randomization

All patients presenting to the Department of Urology at University of California, Irvine, University of Toronto and North Shore-LIJ Health System requiring a flexible ureteroscopy for treatment of their kidney or ureteral stone disease will be approached for enrolment in the study, assuming the inclusion and exclusion criteria detailed below are met. After discussion of the study with potential participants, interested parties will be given a copy of the consent form. The investigator will review and explain the consent form with the potential subject. All information about the study will be provided. Ample time will be given for individuals to ask questions regarding participation and to have questions answered prior to signing the consent form. If so desired, those interested will be given a copy of the consent form to take home so that they may have the opportunity to discuss participation further with family and/or advisors. If an individual chooses to enroll, the consent form will be signed before procedure begins. Once an individual joins the study and informed consent is obtained, the subject will receive a signed copy of the consent form. Individuals may chose not be enrolled in the study or may withdraw from the study at any time without repercussions to subsequent care.

Patients agreeing to participate in the study will be randomized on the day of surgery. Stratified block randomization will be utilized to balance the number of patients with different stone sizes (>1cm, <1cm), kidney, proximal and distal ureteral stones between the two groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients >18 years old.
  • Patients with <2 cm total burden of renal or ureteral stones eligible for flexible ureteroscopic lithotripsy.

排除标准

  • Patients <18 years old.
  • Patients who are not able to give consent for study
  • Patients with active urinary tract infection
  • Pregnant women
  • Patients who have had ureteroscopy, SWL or PCNL for the same stone on the ipsilateral kidney

结局指标

主要结局

Time

时间窗: Day 1 (Day of procedure)

The primary outcome of the proposed study will be the procedure time in minutes measured from the start of the endoscopic access to the end of the procedure including complete fragmentation and stone fragment removal.

次要结局

  • Complications(Days 1-30)
  • Time(Days 1-30)
  • Device efficacy(Procedure day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jaime Landman

Professor of Urology and Radiology

University of California, Irvine

研究点 (2)

Loading locations...

相似试验

已完成
3 期
COMPARISON OF TROXIPIDE WITH RANTIDINE IN THE TREATMENT OF GASTRITIS AND/OR GASTRIC ULCER DISEASE
CTRI/2010/091/000915EMCURE PHARMACEUTICALS LIMITED220
进行中(未招募)
不适用
ENSAYO CLINICO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, DE GRUPOS PARALELOS,, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE TETRACOSÁCTIDO FRENTE A FOSFATO-ACETATO DE BETAMETASONA Y FRENTE A LA COMBINACIÓN DE TETRACOSÁCTIDO Y FOSFATO-ACETATO DE BETAMETASONA PARA EL TRATAMIENTO DE EPISODIOS DE GOTA AGUDA EN PACIENTES CON CONTRAINDICACIÓN PARA TRATAMIENTO CON ANTIINFLAMATORIOS NO ESTEROIDES Y COLCHICINA TITLE: MULTICENTER, RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL WITH PARALLEL GROUPS TO EVALUATE EFFICACY AND SAFETY OF TETRACOSACTIDE VS. BETAMETASONE PHOSPHATE-ACETATE AND VS. COMBINED TETRACOSACTIDE AND BETAMETASONE PHOSPHATE-ACETATE IN PATIENTS WITH ACUTE GOUT AND CONTRAINDICATION FOR TREATMENT WITH BOTH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND COLCHICINE - ECTEFABEEl objetivo es demostrar la equivalencia terapéutica del Tetracosáctida en dosis única frente a Betametasona en dosis única. También son objetivos del ensayo demostrar la superioridad de la combinación de ambos fármacos frente a la monoterapia con cualquiera de ellos en pacientes que presentan un episodio demostrado de artritis gotosa aguda y contraindicación para la prescripción de anti-inflamatorios no esteroides y colchicina, así como evaluar la seguridad de las tres ramas de tratamiento.MedDRA version: 14.0Level: LLTClassification code 10003435Term: Articular goutSystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2011-000069-11-ESFERNADO PEREZ RUIZ
进行中(未招募)
不适用
ENSAYO CLÍNICO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, PARALELO, COMPARADO CON PLACEBO PARA VALORAR LA EFICACIA DEL DOBESILATO CÁLCICO EN EL TRATAMIENTO DE LAS ÚLCERAS SECUNDARIAS A INSUFICIENCIA VENOSA CRÓNICA(RANDOMISED, MULTICENTRIC, DOUBLE BLIND, PARALLEL CLINICAL TRIAL, THAT ASSESS THE EFFICACY OF CALCIUM DOBESILATE COMPARED TO PLACEBO, IN THE TREATMENT OF SKIN ULCERS SECONDARIES TO CHRONIC VENOUS INSUFFICIENCY)
EUCTR2007-002858-37-ESFUNDACIÓN IBEROAMERICANA ITACA
已完成
3 期
A clinical trial to assess immunogenicity and safety of combination vaccine (DTwP-HB) as compared with Active Comparator (DTPw-HB) and to demonstrate the equivalence of three different lots of LBVW0101, in healthy infants at 6, 10 and 14 weeks of age.
CTRI/2009/091/000394G Life Sciences Ltd492
已完成
3 期
A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast CancerChemotherapy-induced Nausea and Vomiting
NCT03403712Helsinn Healthcare SA404